259 results on '"Sieghart, Wolfgang"'
Search Results
2. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
3. Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis
4. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice
5. Cancer and liver cirrhosis: implications on prognosis and management
6. Hepatocellular carcinoma incidence in chronic hepatitis C patients according to sustained virological response ( SVR ) with interferon‐based therapies and baseline characteristics
7. Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study
8. Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
9. Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
10. Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient
11. Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma
12. Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
13. Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma
14. Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?
15. Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case report
16. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation
17. Incidence and mortality trends for biliary tract cancers in Austria
18. Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma
19. Das hepatozelluläre Karzinom
20. Nivolumab Versus Sorafenib Treatment in Advanced Hepatocellular Carcinoma (CheckMate 459): A Randomised, Multicentre, Open-Label, Phase 3 Trial
21. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study
22. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
23. The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
24. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells
25. Hedgehog inhibition with GDC-0449 reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma: 872
26. Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
27. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma
28. Piddosome-controlled liver ploidy is predictive for HCC outcome
29. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis
30. Erythropoietin Treatment Is Associated with More Severe Thrombocytopenia in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy
31. Short‐ and long‐term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
32. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
33. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation
34. Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
35. SAT-486-Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
36. PS-138-PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort
37. SAT-481-Intratumoral mast cell infiltration and recurrence of hepatocellular carcinoma in patients undergoing orthotopic liver transplantation
38. Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
39. Priv. Doz. Dr. Wolfgang Sieghart Researcher of the Month Juni 2013
40. Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
41. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma
42. Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
43. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding – A two decades experience
44. The impact of thyroid hormones on patients with hepatocellular carcinoma
45. Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model
46. Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib
47. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices
48. Osteoponstin expression and presence of EGFR-positive liver macrophage to predict outcome after liver transplantation for hepatocellular carcinoma.
49. Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control
50. Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.